ELSID - Evaluation of a Large Scale Implementation of Disease Management Programmes for patients with type 2 diabetes

ISRCTN ISRCTN08471887
DOI https://doi.org/10.1186/ISRCTN08471887
Secondary identifying numbers N/A
Submission date
22/06/2005
Registration date
20/07/2005
Last edited
02/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Joachim Szecsenyi
Scientific

Vossstrasse 2
Heidelberg
69115
Germany

Phone +49 6221 56 4745
Email joachim.szecsenyi@med.uni-heidelberg.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Scientific titleELSID - Evaluation of a Large Scale Implementation of Disease Management Programmes for patients with type 2 diabete: a randomised controlled trial
Study acronymELSID
Study objectives1. The German-Diabetes-Disease Management Program (DMP 1) is more effective than routine diabetes care (CG)
2. An optimally implemented form of the Diabetes-Disease Management Program (DMP 2) is more effective than the German-Diabetes-DMP(DMP 1).
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedType 2 diabetes
InterventionRandomisation between DMP 1 and DMP 2.

GPs in the DMP 1 group will offer regular consultations at 3- or 6-month intervals including detailed diabetes-specific anamnesis, physical examination including taking blood pressure and analysis of HbA1c. Agreements are made concerning further treatment, eg target values for HbA1c and blood pressure and participation in patient education programmes for diabetes or hypertension. All medical findings and the current medication have to be documented within structured, standardized documentation sheets at each consultation. If required a referral to a specialist (eg ophthalmologist) will be arranged.

In addition, in the DMP 2 group the following interventions are planned: interactive quality circle meetings for the GPs, educational meetings for medical assistants in the practices, outreach visits including the practice team, homepage with 'best practice' examples.
Intervention typeOther
Primary outcome measureHbA1c and blood pressure.
Secondary outcome measuresPrescriptions, hospitalizations, referrals, severe complications, SCORE risk chart.
Overall study start date01/08/2005
Completion date31/07/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants4000 patients
Key inclusion criteriaControl group: Practices and patients with type 2 diabetes not participating in a Diabetes-Disease Management Programme
DMP 1 and DMP 2 group: Practices and patients with type 2 diabetes participating in a Diabetes-Disease Management Programme
Key exclusion criteriaControl group: Practices or Patients participating in any Disease Management Programmes
Date of first enrolment01/08/2005
Date of final enrolment31/07/2008

Locations

Countries of recruitment

  • Germany

Study participating centre

Vossstrasse 2
Heidelberg
69115
Germany

Sponsor information

AOK-Bundesverband (Germany)
Industry

Kortrijker Strasse 1
Bonn
53177
Germany

Phone +49 228 843 0
Email info@bv.aok.de
Website http://www.aok-bv.de
ROR logo "ROR" https://ror.org/004cmqw89

Funders

Funder type

Industry

AOK-Bundesverband

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 04/10/2005 Yes No

Editorial Notes

02/10/2017: internal review.